Suppr超能文献

术前免疫营养对细胞减灭术和 HIPEC 后腹膜转移患者术后主要并发症的影响。

Effect of Preoperative Immunonutrition on Postoperative Major Morbidity after Cytoreductive Surgery and HIPEC in Patients with Peritoneal Metastasis.

机构信息

Peritoneal Carcinomatosis Unit, General Surgery Department, Elche University General Hospital, 03202 Elche, Spain.

Department of Medicine, University Jaume I (UJI), 12004 Valencia, Spain.

出版信息

Nutrients. 2021 Jun 23;13(7):2147. doi: 10.3390/nu13072147.

Abstract

The effect of preoperative immunonutrition intake on postoperative major complications in patients following cytoreductive surgery (CRS) with or without hyperthermic intraperitoneal chemotherapy (HIPEC) was assessed. The accuracy of C-Reactive Protein (CRP) for detecting postoperative complications was also analyzed. Patients treated within a peritoneal carcinomatosis program in which a complete or optimal cytoreduction was achieved were retrospectively analyzed. They were divided into two groups based on whether preoperative immunonutrition (IMN) or not (non-IMN) were administered. Clinical and surgical variables and postoperative complications were gathered. Predictive values of major morbidity of CRP during the first 3 postoperative days (POD) were also evaluated. A total of 107 patients were included, 48 belonging to the IMN group and 59 to the non-IMN group. In multivariate analysis immunonutrition (OR 0.247; 95%CI 0.071-0.859; = 0.028), and the number of visceral resections (OR 1.947; 95%CI 1.086-3.488; = 0.025) emerged as independent factors associated with postoperative major morbidity. CRP values above 103 mg/L yielded a negative predictive value of 84%. Preoperative intake of immunonutrition was associated with a decrease of postoperative major morbidity and might be recommended to patients with peritoneal carcinomatosis following CRS. Measuring CRP levels during the 3 first postoperative days is useful to rule out major morbidity.

摘要

评估了术前免疫营养摄入对接受细胞减灭术(CRS)联合或不联合腹腔内热化疗(HIPEC)的患者术后主要并发症的影响。还分析了 C-反应蛋白(CRP)检测术后并发症的准确性。对在腹膜肿瘤病计划中接受治疗的患者进行回顾性分析,这些患者在计划中实现了完全或最佳的细胞减灭术。根据是否给予术前免疫营养(IMN)将他们分为两组。收集了临床和手术变量以及术后并发症。还评估了 CRP 在术后前 3 天(POD)期间预测主要发病率的预测值。共纳入 107 例患者,其中 48 例为 IMN 组,59 例为非 IMN 组。多变量分析显示,免疫营养(OR 0.247;95%CI 0.071-0.859;P = 0.028)和内脏切除术数量(OR 1.947;95%CI 1.086-3.488;P = 0.025)是与术后主要发病率相关的独立因素。CRP 值高于 103 mg/L 时,阴性预测值为 84%。术前摄入免疫营养与术后主要发病率降低有关,可能会推荐给接受 CRS 后的腹膜肿瘤病患者。在术后前 3 天测量 CRP 水平有助于排除主要发病率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dac/8308234/0cd6120c1e7f/nutrients-13-02147-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验